The following populations have no published exposure data and would generally be excluded from research-context use: - People who are pregnant, trying to become pregnant, or breastfeeding
MOTS-c / Humanin Blend Combines two well-known mitochondrial research compounds that are frequently studied for their complementary roles in cellular signaling and metabolic function
This is the single most important section for anyone weighing the risks of BPC-157, and the honest answer is uncomfortable: there are zero completed Phase III human clinical trials for BPC-157, and the peptide has never received marketing approval from any major regulator
Most data comes from individual peptide research, and human clinical trials for the combination are completely absent from peer-reviewed literature
And I realize a huge component of the drugs that pros, and increasingly amateurs use is specifically to aid recovery so they can train more and train harder, etc